Home|
Japanese Drug Maker to Pay $1.1 Billion for U.S. Rival Shionogi & Company, the Japanese drug maker, plans to buy an American rival, Sciele Pharma for $1.1 billion. Home > Rss Directory > Business > NY Time |
|
Japanese to Buy U.S. Drug Maker Shionogi & Company plans to buy an American rival, Sciele Pharma, for $1.1 billion, the fourth big overseas deals in nine months by a Japanese company eager to expand overseas. Home > Rss Directory > Business > NY Time |
|
Meet Hiroyuki Nishimura, the Bad Boy of the Japanese Internet I'm sitting in a sterile white conference room waiting for Hiroyuki Nishimura. Japan is a nation where the 3:17 train arrives every day at 3:17 — not 3:16 or 3:18 — and Nishimura is 45 minutes late. The PR assistant who painstakingly coordinated our interview, a typical salarym Home > Rss Directory > Business > Wired News |
|
CVS to Pay $2.54 Billion for West Coast Drug Chain CVS Caremark said that it would buy its West Coast rival Longs Drugs Stores in a $2.54 billion deal that would allow it to expand in states like California. Home > Rss Directory > Business > NY Time |
|
Japanese Drug Company Bids for U.S. Biotech Firm Japan’s Takeda Pharmaceutical has agreed to pay $8.8 billion in cash for Millennium Pharmaceuticals, one of the earliest American genomics companies. Home > Rss Directory > Business > NY Time |
|
Frustrated Game Maker Extends Offer for a Rival - New York Times CBC.caFrustrated Game Maker Extends Offer for a RivalNew York Times - 2 hours agoBy MATT RICHTEL SAN FRANCISCO - Electronic Arts on Friday extended its $2 billion tender offer for a rival video game maker, Take-Two Interactive, through May 16.Electronic Arts extend Home > Rss Directory > General > Google News |
|
A Brief Tour of the Japanese Web I'm sitting in a smoky room on the second floor of a Tully's Coffee in Western Tokyo, looking over the shoulder of Ichiroo Kiyota as he types on his laptop. Kiyota, an executive at Six Apart Japan, is showing me around some of the most popular — and useless — Web apps in the countr Home > Rss Directory > Business > Wired News |
|
Roche to Buy Maker of Drug-Test Gear The Swiss pharmaceuticals company said that it would pay $3.1 billion for Ventana Medical Systems. Home > Rss Directory > Business > NY Time |
|
AHN - German Drug-Maker To Buy Illinois-based APP Pharmaceuticals For $3.7B (AHN) - German-based Fresnius SE will buy U.S. generic drug-maker APP Pharmaceuticals for $3.7 billion. - Mon, 7 Jul 2008 12:44:42 GMT (AHN) Home > Rss Directory > Business > AllHeadline |
|
In Trial, Alaska Says Lilly Concealed Risks of a Schizophrenia Drug The state is asking the drug maker to pay for the medical expenses of Medicaid patients who have contracted diabetes or other diseases after taking the drug Zyprexa. Home > Rss Directory > Business > NY Time |
|
Teva Buys Drug Rival, Barr, for $7.46 Billion The combined company would be a generic drug powerhouse operating in more than 60 countries. Together, Barr and Teva had revenue of about $11.9 billion in 2007. Home > Rss Directory > Business > NY Time |
|
Stanford to Limit Drug Maker Financing Stanford University is concerned about the practice that has led drug makers to pay for the annual refresher courses of most of the country’s doctors. Home > Rss Directory > Business > NY Time |
|
Walgreen drops bid for rival Longs Drug - MarketWatch ReutersWalgreen drops bid for rival Longs DrugMarketWatch - 57 minutes agoBy Matt Andrejczak, MarketWatch SAN FRANCISCO (MarketWatch) -- Walgreen Co. late Wednesday pulled its proposal to buy Longs Drug Stores for $75 a share in cash, leaving the door open for CVS Carem Home > Rss Directory > General > Google News |
|
Drug Companies Get Healthy, but at Whose Expense? News from Portfolio.com Also on Portfolio Esquire, E-Ink: Future of Print? Hollywood's Sudden Cash Crunch Even Conservatives Hate Michael Savage Subscribe to Portfolio magazine Trevor Foltz was six months old last fall, Home > Rss Directory > General > Wired News |
|
Drug Companies Get Healthy, but at Whose Expense? News from Portfolio.com Also on Portfolio Esquire, E-Ink: Future of Print? Hollywood's Sudden Cash Crunch Even Conservatives Hate Michael Savage Subscribe to Portfolio magazine Trevor Foltz was six months old last fall, Home > Rss Directory > Technology > Wired News |
|
German Health Care Company Buying Intravenous Drug Firm The German health care company Fresenius said it had agreed to buy the American generic drug maker APP Pharmaceuticals for $3.7 billion. Home > Rss Directory > Business > NY Time |
|
Game Maker Retracts Bid for a Rival Electronic Arts said that it has withdrawn its $2 billion tender offer to purchase its smaller rival, ending a six-month long hostile takeover bid. Home > Rss Directory > Business > NY Time |
|
Game Maker Retracts Bid for a Rival Electronic Arts said that it has withdrawn its $2 billion tender offer to purchase its smaller rival, ending a six-month long hostile takeover bid. Home > Rss Directory > Technology > NY Time |
|
Botox maker lashes out with new drug - Boston Herald ABC NewsBotox maker lashes out with new drugBoston Herald - 50 minutes agoBy Christine McConville Coming soon to beauty vendors near you: Latisse, the first prescription product for longer, thicker lashes.FDA OKs 1st Eyelash Drug Latisse WebMDFDA approves Allerg Home > Rss Directory > General > Google News |
|
Japanese browser maker taking on IE, Firefox A Japanese software company is stepping up international promotion of its Web browser in the hope of carving out a 5 percent share over the next few years of a market dominated by Internet Explorer and Firefox.T Home > Rss Directory > Technology > InfoWorld |